Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: Development and characterization

References

• André N, Braguer D, Brasseur G, Gonçalves A, Lemesle-Meunier D, Guise S, Jordan MA, Briand C. (2000). Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells’. Cancer Res, 60, 5349–5353.
   PubMed Web of Science ®Google Scholar
• André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D. (2002). Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett, 532, 256–260.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L. (2010). Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release, 145, 17–25.
   PubMed Web of Science ®Google Scholar
• Cheng SM, Pabba S, Torchilin VP, Fowle W, Kimpfler A, Schubert R, Weissig V. (2005). Towards mitochondriaspecific delivery of apoptosis inducing agents: DQAsomal incorporated paclitaxel. J Drug Del Sci Technol, 15, 81–86.
   Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release, 63, 19–30.
   PubMed Web of Science ®Google Scholar
• D’Souza GG, Rammohan R, Cheng SM, Torchilin VP, Weissig V. (2003). DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release, 92, 189–197.
   PubMed Web of Science ®Google Scholar
• Derycke AS, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, Huwyler J, Missiaen L, de Witte PA. (2004). Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst, 96, 1620–1630.
   PubMed Web of Science ®Google Scholar
• Domnina LV, Ivanova OY, Pletjushkina OY, Fetisova EK, Chernyak BV, Skulachev VP, Vasiliev JM. (2004). Marginal blebbing during the early stages of TNF-induced apoptosis indicates alteration in actomyosin contractility. Cell Biol Int, 28, 471–475.
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. (2009). Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur J Pharm Biopharm, 72, 9–17.
   PubMed Web of Science ®Google Scholar
• D’Souza GG, Cheng SM, Boddapati SV, Horobin RW, Weissig V. (2008). Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel. J Drug Target, 16, 578–585.
   PubMed Web of Science ®Google Scholar
• Eavarone DA, Yu X, Bellamkonda RV. (2000). Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J Biomed Mater Res, 51, 10–14.
   PubMed Web of Science ®Google Scholar
• Gupta S. (2001). Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci, 69, 2957–2964.
   PubMed Web of Science ®Google Scholar
• Huebers HA, Finch CA. (1987). The physiology of transferrin and transferrin receptors. Physiol Rev, 67, 520–582.
   PubMed Web of Science ®Google Scholar
• Iinuma H, Maruyama K, Okinaga K, Sasaki K, Sekine T, Ishida O, Ogiwara N, Johkura K, Yonemura Y. (2002). Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer, 99, 130–137.
   PubMed Web of Science ®Google Scholar
• Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM. (2001). Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta, 1515, 144–158.
   PubMed Web of Science ®Google Scholar
• Johnstone RW, Ruefli AA, Lowe SW. (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108, 153–164.
   PubMed Web of Science ®Google Scholar
• Kaiser E, Colescott RL, Bossinger CD, Cook PI. (1970). Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem, 34, 595–598.
   PubMed Web of Science ®Google Scholar
• Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, Maruyama K, Kamiya H, Harashima H. (2004). Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry, 43, 5618–5628.
   PubMed Web of Science ®Google Scholar
• Li X, Ding L, Xu Y, Wang Y, Ping Q. (2009). Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm, 373, 116–123.
   PubMed Web of Science ®Google Scholar
• Li YC, Fung KP, Kwok TT, Lee CY, Suen YK, Kong SK. (2002). Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicin-resistant HepG2 cells. Life Sci, 71, 2729–2740.
   PubMed Web of Science ®Google Scholar
• Li Y, Ogris M, Wagner E, Pelisek J, Rüffer M. (2003). Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm, 259, 93–101.
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55–63.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, Mahor S, Gupta PN, Rawat A, Vyas SP. (2007). Cell-selective mitochondrial targeting: progress in mitochondrial medicine. Curr Drug Deliv, 4, 211–224.
   PubMedGoogle Scholar
• Pfeiffer DR, Gudz TI, Novgorodov SA, Erdahl WL. (1995). The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition. J Biol Chem, 270, 4923–4932.
   PubMed Web of Science ®Google Scholar
• Qian ZM, Li H, Sun H, Ho K. (2002). Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 54, 561–587.
   PubMed Web of Science ®Google Scholar
• Singh M. (1999). Transferrin As A targeting ligand for liposomes and anticancer drugs. Curr Pharm Des, 5, 443–451.
   PubMed Web of Science ®Google Scholar
• Soni V, Kohli DV, Jain SK. (2005). Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target, 13, 245–250.
   PubMed Web of Science ®Google Scholar
• Vaidya B, Paliwal R, Rai S, Khatri K, Goyal AK, Mishra N, Vyas SP. (2009). Cell-selective mitochondrial targeting: A new approach for cancer therapy. Cancer Ther, 7(A), 141–148.
   Google Scholar
• Weissig V, Lasch J, Erdos G, Meyer HW, Rowe TC, Hughes J. (1998). DQAsomes: a novel potential drug and gene delivery system made from Dequalinium. Pharm Res, 15, 334–337.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Shinohara Y, Kakudo T, Chaki S, Futaki S, Kamiya H, Harashima H. (2005). Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int J Pharm, 303, 1–7.
   PubMed Web of Science ®Google Scholar
• Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, Kim DD. (2007). Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm, 338, 317–326.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T. (2004). Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway. Acta Pharmacol Sin, 25, 691–698.
   PubMed Web of Science ®Google Scholar